Contrasting Hyperfine (NASDAQ:HYPR) & Echo Therapeutics (OTCMKTS:ECTE)
Contrasting Hyperfine (NASDAQ:HYPR) & Echo Therapeutics (OTCMKTS:ECTE)
This table compares Echo Therapeutics and Hyperfine's net margins, return on equity and return on assets.Echo Therapeutics (OTCMKTS:ECTE – Get Rating) and Hyperfine (NASDAQ:HYPR – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.
Echo Treateutics(場外交易代碼：ECTE-GET Rating)和超精細(納斯達克：HYPR-GET Rating)都是醫療公司，但哪項業務更優越？我們將根據這兩家公司的風險、股息、盈利能力、收益、分析師建議、估值和機構所有權的強弱對它們進行比較。
Valuation & Earnings
估值與收益
This table compares Echo Therapeutics and Hyperfine's revenue, earnings per share (EPS) and valuation.
下表比較了Echo Treeutics和HyperFine的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Echo Therapeutics | N/A | N/A | N/A | N/A | N/A |
| Hyperfine | $1.50 million | 40.46 | -$64.85 million | ($3.59) | -0.24 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 本益比 | |
| 回聲治療學 | 不適用 | 不適用 | 不適用 | 不適用 | 不適用 |
| 超細 | 150萬美元 | 40.46 | -6,485萬元 | ($3.59) | -0.24 |
Echo Therapeutics has higher earnings, but lower revenue than Hyperfine.
Echo Treateutics的收益更高，但收入比HyperFine低。
Insider & Institutional Ownership
內部人與機構所有權
Profitability
盈利能力
This table compares Echo Therapeutics and Hyperfine's net margins, return on equity and return on assets.
此表比較了Echo Treeutics和HyperFine的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Echo Therapeutics | N/A | N/A | N/A |
| Hyperfine | -1,479.40% | -54.01% | -49.87% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 回聲治療學 | 不適用 | 不適用 | 不適用 |
| 超細 | -1,479.40% | -54.01% | -49.87% |
Analyst Ratings
分析師評級
This is a breakdown of current ratings and recommmendations for Echo Therapeutics and Hyperfine, as provided by MarketBeat.
這是MarketBeat提供的Echo治療和HyperFine的當前評級和建議的細目。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Echo Therapeutics | 0 | 0 | 0 | 0 | N/A |
| Hyperfine | 0 | 1 | 2 | 0 | 2.67 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 回聲治療學 | 0 | 0 | 0 | 0 | 不適用 |
| 超細 | 0 | 1 | 2 | 0 | 2.67 |
Hyperfine has a consensus price target of $4.30, suggesting a potential upside of 400.00%. Given Hyperfine's higher possible upside, analysts plainly believe Hyperfine is more favorable than Echo Therapeutics.
HyperFine的普遍目標價為4.3美元，暗示潛在漲幅為400.00%。考慮到HyperFine的更高可能上行空間，分析師們顯然認為HyperFine比Echo治療公司更有利。
Summary
摘要
Hyperfine beats Echo Therapeutics on 5 of the 8 factors compared between the two stocks.
在兩只股票之間的8個因素中，有5個因素超精細擊敗了Echo治療公司。
About Echo Therapeutics
關於Echo Treateutics
(Get Rating)
(獲取評級)
Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.
Echo治療公司是一家醫療設備公司，致力於開發用於糖尿病門診市場的非侵入性、無線連續血糖監測系統。它提供無針頭皮膚準備設備作為平臺技術，允許增強皮膚滲透性，從而能夠提取葡萄糖等分析物並提供局部藥物。該公司成立於1989年，總部設在新澤西州的伊塞林。
About Hyperfine
關於超精細
(Get Rating)
(獲取評級)
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Hyperfiny，Inc.提供成像、監測和磁共振成像產品。它提供Swoop可攜式磁共振成像系統，通過硬體和軟體服務的組合來滿足醫療點式醫學成像方面未得到滿足的需求。該公司成立於2014年，總部設在康涅狄格州吉爾福德。
Receive News & Ratings for Echo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Echo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受Echo治療日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Echo治療公司和相關公司的最新新聞和分析師評級的每日簡要摘要。